Financing ·
Jaguar Health declares special stock dividend of Series R Preferred convertible at 5-to-1 ratio
JAGXJaguar Health, Inc.
Jaguar Health declared a special one-time stock dividend of one share of Series R Convertible Preferred Stock for each outstanding share of Common Stock and certain warrants, with a record date of October 13, 2026. Each preferred share converts into five shares of common stock on November 2, 2026, potentially issuing up to 11.4 million additional common shares. The company also amended royalty agreements with Uptown Capital and Streeterville Capital to extend monthly payment start dates to January 1, 2027, and extended the maturity date of a $6.2 million secured note to January 1, 2027. Jaguar Health is a commercial-stage pharmaceuticals company developing novel prescription medicines for gastrointestinal distress.